belumosudil 200 MG Oral Tablet
- RxCUI
- 2564031
- RxNorm name
- belumosudil 200 MG Oral Tablet
- Display name
- belumosudil 200 MG Oral Tablet
- Full name
- belumosudil 200 MG Oral Tablet
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:38:47
UNII Substances#
No records found.
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Rezurock | BELUMOSUDIL | Kadmon Pharmaceuticals, LLC | 102e4ef4-7f84-4e34-8df1-479c24d1575d | 2026-04-07 | Warnings, Adverse reactions | 2564031 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm string | TTY | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 102e4ef4-7f84-4e34-8df1-479c24d1575d | belumosudil 200 MG Oral Tablet | PSN | 11 | These highlights do not include all the information needed to use REZUROCK safely and effectively. See full prescribing information for REZUROCK. REZUROCK ® (belumosudil) tablets, for oral use Initial U.S. Approval: 2021 | 20260407 |
| 102e4ef4-7f84-4e34-8df1-479c24d1575d | belumosudil 200 MG Oral Tablet | SCD | 11 | These highlights do not include all the information needed to use REZUROCK safely and effectively. See full prescribing information for REZUROCK. REZUROCK ® (belumosudil) tablets, for oral use Initial U.S. Approval: 2021 | 20260407 |
| 102e4ef4-7f84-4e34-8df1-479c24d1575d | belumosudil (as belumosudil mesylate) 200 MG Oral Tablet | SY | 11 | These highlights do not include all the information needed to use REZUROCK safely and effectively. See full prescribing information for REZUROCK. REZUROCK ® (belumosudil) tablets, for oral use Initial U.S. Approval: 2021 | 20260407 |